Trexquant Investment LP Invitae Corp Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$26.09 - $40.4 $469,202 - $726,553	-17,984 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$33.06 - $56.93 $124,966 - $215,195	-3,780 Reduced 17.37%	17,984 $687,000
Q4 2020 Feb 11, 2021	BUY	$39.09 - $57.4 $850,754 - $1.25 Million	21,764 New	21,764 $910,000
Q1 2020 May 08, 2020	SELL	$7.64 - $27.5 $765,856 - $2.76 Million	-100,243 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$15.02 - $20.57 $1.15 Million - $1.58 Million	76,750 Added 326.69%	100,243 $1.62 Million

Q3 2019 Nov 08, 2019	BUY	$18.85 - $27.5 $442,843 - $646,057	23,493 New	23,493 $453,000
Q1 2019 May 13, 2019	SELL	$10.65 - $25.75 $152,263 - $368,147	-14,297 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$9.26 - $16.38 $91,340 - $161,572	-9,864 Reduced 40.83%	14,297 $158,000
Q3 2018 Nov 09, 2018	BUY	$7.54 - $18.31 $182,173 - $442,387	24,161 New	24,161 $404,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.